WEPOX Injection IP

Product Description

Wepox Erythropoietin Injection is a medication used to treat anemia caused by chronic kidney disease, cancer chemotherapy, or HIV therapy. It works by stimulating the production of red blood cells in the body. This injection is administered under the skin or into a vein by a healthcare professional.

Here are some frequently asked questions (FAQs) about WEPOX Injection IP:

1. What is WEPOX Injection IP?WEPOX Injection IP is a medication containing recombinant human erythropoietin (rHuEPO), a synthetic version of the hormone erythropoietin. It is used to stimulate the production of red blood cells in the body.

2. What conditions does WEPOX Injection IP treat?WEPOX Injection IP is primarily used in the treatment of anemia associated with chronic kidney disease (CKD), including patients on dialysis and those not on dialysis. It may also be used to treat anemia in patients with certain types of cancer receiving chemotherapy and in patients with HIV infection taking zidovudine.

3. How does WEPOX Injection IP work?WEPOX Injection IP works by stimulating the bone marrow to produce more red blood cells. Erythropoietin is a natural hormone produced by the kidneys in response to low oxygen levels in the blood. Recombinant human erythropoietin mimics the action of endogenous erythropoietin.

4. How is WEPOX Injection IP administered?WEPOX Injection IP is administered as an injection under the skin (subcutaneously) or directly into a vein (intravenously). The dosage and frequency of administration will depend on the patient's condition, including the severity of anemia and the underlying cause.

5. What are the common side effects of WEPOX Injection IP?Common side effects of WEPOX Injection IP may include headache, nausea, vomiting, diarrhea, high blood pressure, joint or muscle pain, fever, and injection site reactions such as redness, swelling, or pain. In some cases, WEPOX Injection IP may cause serious cardiovascular or blood clotting complications.

6. Who should not take WEPOX Injection IP?WEPOX Injection IP may not be suitable for everyone. Patients with uncontrolled high blood pressure, certain types of cancer, or a history of allergic reactions to erythropoietin or any other component of the medication may not be able to take WEPOX Injection IP. It's important to discuss your medical history and any medications you are currently taking with your healthcare provider before starting treatment.

7. Is WEPOX Injection IP safe during pregnancy and breastfeeding?WEPOX Injection IP should be used during pregnancy only if the potential benefits justify the potential risks to the fetus. It is not known whether WEPOX Injection IP passes into breast milk, so breastfeeding is typically not recommended while receiving treatment with WEPOX Injection IP. It's essential to discuss the risks and benefits with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.

8. Are there any interactions with other medications?WEPOX Injection IP may interact with certain medications, including other drugs that stimulate red blood cell production (such as darbepoetin alfa) and certain antihypertensive medications. It's important to inform your healthcare provider about all medications you are taking, including prescription drugs, over-the-counter medications, vitamins, and supplements, to avoid potential interactions.

Designed for Safe and Effective Anemia Management

WEPOX Injection offers precise dosing of erythropoietin to stimulate red blood cell production in patients with anemia related to chronic illness. Each pre-filled syringe delivers 4000 IU in a sterile, preservative-free format. The clear, colorless solution ensures high quality, with safety guidelines in place to prevent use if contaminated or discolored. Healthcare professionals benefit from the easy administration and reliable hematological response.


Pharmaceutical Grade Quality with Extensive Applications

WEPOX is suitable for various indications such as anemia linked to chronic renal failure, oncology, and HIV infection. Its recombinant protein formulation maintains a pH of approximately 6.9 to 7.4 and remains odorless and visually clear to ensure optimal patient safety. The product is manufactured under strict GMP compliance and distributed by certified dealers and healthcare suppliers throughout India.